US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 3.039
  • -0.081-2.60%
Trading Dec 12 13:23 ET
300.68MMarket Cap-6.72P/E (TTM)

About AC Immune Company

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Company Profile

SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andrea Pfeifer, PhD
  • Chief Executive Officer and Director
  • --
  • Christopher Roberts
  • Chief Financial Officer
  • --
  • Dr. Madiha Derouazi, PhD
  • Chief Scientific Officer
  • --
  • Howard Donovan
  • Chief Human Resources Officer
  • --
  • Jean-Fabien Monin
  • Chief Administrative Officer
  • --
  • Dr. Nuno Mendonça, M.D.
  • Chief Medical Officer
  • --
  • Piergiorgio Donati
  • Chief Technical Operations Officer
  • --
  • Dr. Bojana Portmann, PhD
  • Vice President, IP and Business Development
  • --
  • Dr. Julien Rongere, PhD
  • Senior Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Dr. Gary Waanders, PhD
  • Senior Vice President, Investor Relations and Corporate Communications
  • --
  • Mark Danton
  • Senior Vice President Information Systems and Artificial Intelligence
  • --
  • Dr. Olivier Sol, M.D.
  • Vice President and Head of Clinical Development
  • --
  • Dr. Douglas E. WilliaPhD
  • Chairman of the Board
  • --
  • Professor Dr. Monika Butler, PhD
  • Vice Chairman of the Board and Director
  • --
  • Professor Carl June, M.D.
  • Independent Director
  • --
  • Dr. Werner Lanthaler, PhD
  • Independent Director
  • --
  • Monica Shaw
  • Independent Director
  • --
  • Dr. Roy Twyman, M.D.
  • Independent Director
  • --
  • Dr. Marie Kosco-Vilbois, PhD
  • Scientific Advisor
  • --
  • Dr. Julian Gray, PhD
  • Clinical Advisor
  • --
  • Alexandre Caratsch
  • General Counsel
  • --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+1.11%
Microsoft
MSFT
+0.96%
Cisco
CSCO
+0.98%
Apple
AAPL
+0.83%
Alibaba
BABA
+0.22%

Unlock the Full List